Get started

Pharmastocks

Supriya Lifeciences Episodic Pivot TradeSupriya Lifesciences made a gap up (episodic pivot) on 8th Feb due to its blockbuster earnings, intresting part is even in the carnage of Smallcap & Midcaps the gap has been sustained continuously for 3 consecutive days, and never did it break the low of the EP candle. This shows strength in the scrip and I believe in the coming days once the market recovers, this scrip will move easily towards 400, 440 zone. Stoploss 312 DISCLAIMER* This analysis is only for educational purpose. I am not a SEBI Registered Analyst/Advisor. Please consult your financial advisor before taking any position and please use a Stop Loss for any Investments/Trading Positions. It is your hard earned money so give risk management your highest attention. Do take this disclaimer seriously.
NSE:SUPRIYALong
by nishant_bhatt
DIVIS LAB: H&S ContinuationFrom Mar'23 bottom of 2730 stock has rallied and made a high of 3934 in Aug'23. Post that stock has undergone into a correction which already concluded at Nov'23 bottom of 3295. From there stock has rallied again and broken it's previous swing high made in Aug'23. The recent price action suggests that stock has formed a Continuation H&S and given a breakout on 26th dec'23 and trading well above it's neckline. The measured target for this pattern is coming in the region of 4370-4400 zone.
NSE:DIVISLABLong
by TradingSutra
NGL Fine Chem Ltd | a Momentum pharma stockNGL Fine Chem Ltd | a Momentum pharma stock Established in 1981, NGL Fine-Chem Limited manufacturers and markets APIs, Intermediates and Finished Dosage forms for human and animal pharmaceutical product. It caters to various Indian and global companies with high quality and reliable products. Financial: Market Cap = 1,382 Cr. ROCE = 11.5 % ROE = 9.31 % Debt to equity = 0.11 Promoter holding = 73.1 % Piotroski score = 4.00 Quick ratio = 2.06 Current ratio = 2.58 Return on assets = 7.11 % Profit Var 3Yrs = 18.5 % Sales growth 3Years = 21.8 % Pledged percentage = 0.00 % in Technically you can see monthly and weekly strong RSI Momentum financially also debt free company as well as company has good capex plan in comming years so this will be next multibagger if hold for long time. Note: I am not SEBI registered financial Adviser. I solely present my views on chart .I do not charge any kind of service. This is not buy sell recommendation. If you like my ideas than like ,boost and follow me for more ideas. Thanks and comment freely
NSE:NGLFINELong
by Momentuminvesting5540
Sequent Scientific PE is negative at -42 THE CARLYLE GROUP ACQUIRES A MAJORITY STAKE IN SEQUENT SCIENTIFIC LIMITED Shares of Sequent Scientific soared over 9 percent in early trade on September 15 after the company's board approved the sale of its API (Active Pharmaceutical Ingredient) facility in Thane Sequent Scientific (NSE:SEQUENT) delivers shareholders decent 8.8% CAGR over 5 years Sequent Scientific shares jump 15% after terminating Tineta Pharma's proposed acquisition mutual funds have increased stake from 0.25% to 1% DII also increasing stake significantly stock has come out of accumulation Phase!!!
NSE:SEQUENTLong
by rsptraders2017
Long TRADE in LUPIN PHARMA Any who wants to add a quality stock in their demat can be go with LUPIN because lupin pharma share has been in very good strong upward momentum from the last 6 months and higher chances of that it will continue its upward journey .Because of the pattern of the share is like first go up and then go down , then again go up and then some downwoard moves , from last almost 1to2 months this process can be shown in charts also , and you can also see very well , so anyone who wants to outshine their portfolio can add this at their own risk management , at now level lupin share has favourable risk reward ratio , in all my ideas published in the trading view has a almost target of the 3 to 4 percent , after 3 to 4 percent target achieved my target is done.3to4 percent counts on current price which is shown in chart as well , so from my side this is good bet previously i shared ANANT RAJ in which almost 3 percent target is DONE AND DUSTED , and IMPORTANT NOTICE:-In my observation and analysis this share has can move without any market support , this share has countinuesly outperform market when our market are flat or consolidating between the area .WAITING TIME is almost 10 to 15 days holding period and , stop loss is nearly 1.5 percent of the current share price as shown in the charts ,, so anyone who can love pharma sector can go with this share with their risk capacity. in my observation this share can start upward journey soon , and yes this share can go up slow as seev in previous chart so dont go for very quick or fast move , this share headed upward slowly slowly . in my experience when a small fall occurs this share fill the fall within 5to6 days like slow and steady , so thanks for reading my long message if you read my message till now than you are amazing person and have a very serious mind in trading , because most of the people don't read this large message ha ha ha ha ha DISCLAIMER:-I have already invested in this share , and all profit and loss in this share is BSE:LUPIN yours , my work is to share idea of the good company in which you will make a good return, and if you earn profit from this share so please feel free to comment in the comment section ,
BSE:LUPINLong
by Parthupadhyay67
Investment pick- Marksans pharmaMonthly chart analysis of Marksans pharma reveals a beautiful cup and handle breakout in the stock. We have seen an ATH breakout already and a consolidation/retracement is bound to happen. The stock is looking strong for multibagger returns with the best buy level for a positional trade is the range of 95-105 Keep this stock in your watchlist. For investment, stock can be added at CMP as well with buy on dips strategy. Stock fundamentals: Category-Midcap Sector-Pharma Industry-Pharma(Bulk drugs) 10 Year compounded profit growth:- 19% Ratios at CMP:- Stock PE:-19 ; Ind. PE:- 26 Debt to equity:- 0.07 (negligible) ROCE:- 22%; ROE:-20% ; P/B:- 3.07; PEG:- 0.34
NSE:MARKSANSLong
by chartistamey
2
Low risk swing trade in #SOLARASeems like Solara Active Pharma has bottomed out. With the recent high volume followed by tight inside candles + inside dojis, this is a picture perfect setup for swing trade. Pharma sector is in an uptrend so can expect #SOLARA to jump the wagon as well. Enter @ CMP Stoploss 322 *DISCLAIMER* This analysis is only for educational purpose. I am not a SEBI Registered Analyst/Advisor. Please consult your financial advisor before taking any position and please use a Stop Loss for any Investments/Trading Positions. It is your hard earned money so give risk management your highest attention. Do take this disclaimer seriously.
NSE:SOLARALong
by nishant_bhatt